Title : Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study.

Pub. Date : 2015 Aug 13

PMID : 26116658






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 study. ibrutinib Bruton tyrosine kinase Homo sapiens